Endeavor Health
Trial Pipeline
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
NCT07405554
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
NCT06828406
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
NCT06861920
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
NCT06898034
Prenatal Sonographic Prediction of Placental Histology and Function
NCT06022458
Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy
NCT06314009
Effects of TNF Blockade on Human BPH/LUTS
NCT06062875
Non Inferiority Trial Investigating Surfactants Administered Via MIST
NCT06074380
Prophylactic Minimally Invasive Surfactant Evaluation
NCT06007547
Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project
NCT06004674
IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
NCT04153422
Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia
NCT05953428
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
NCT05626621
Furthering Equity Through Infant Feeding EDucation and Support
NCT05441709
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407
Long Term Outcomes Following Hernia Repair With Mesh
NCT04578340
Methadone and Quality of Postoperative Recovery
NCT03168958
Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
NCT03491761
Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery
NCT03893734
Paired-Ring Mitral Annuloplasty Ring Sizing Device
NCT06965725
Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo
NCT05801679
Quality of Recovery From Mastectomy With and Without PECS Blocks
NCT05795413
Splint Users' Satisfaction and Functional Status With Custom Finger Splints
NCT05903391
The Cascade Feasibility Pilot (HF) Phase 3
NCT04993287
The CASCADE HF Soft Launch and Calibration Phase I and II
NCT04738279
One Key Question: Pilot Study at NorthShore
NCT03947788
Protocol for Admission Toxigenic C. Difficile Surveillance
NCT04014608
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
NCT01979588
The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period
NCT01739699
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 6 |
| Phase 3 | 1 |
| Phase 4 | 38 |
What the Pipeline for Endeavor Health Shows
According to the ClinicalTrials.gov registry, Endeavor Health is linked to 115 US clinical trials across every stage of research activity. Of those, 105 studies are currently recruiting — about 91% of the sponsor's indexed portfolio — and 7 are already marked complete, representing roughly 6% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Endeavor Health reports 39 late-stage studies (Phase 3 and Phase 4 combined) and 6 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Endeavor Health is Heart Failure with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.